Effective treatment for Cryptosporidium infection in immunocompromised patients has yet to be found. We report a rodent model of persistent Cryptosporidium infection. Sprague-Dawley rats were injected subcutaneously twice a week for 8 weeks with 25 mg of hydrocortisone acetate. Fed a regular low-protein diet for 9 weeks, they were challenged once with 105 calf Cryptosporidium oocysts 5 weeks after the start of the hydrocortisone acetate regimen. Oocyst shedding was evaluated in feces daily by using a carbolfuchsin-staining method. Rats shed oocysts from days 2 to 9 after ingestion and developed a persistent infection for more than 38 days. Excretion was lower after subsequent parasite challenges, suggesting that a degree of protection developed progressively. The results suggest that this experimental model provides a procedure for screening candidate therapeutic agents.
Cryptosporidium sp. is a coccidian parasite which infects a wide variety of host species, including humans (18) , invading different mucosal surfaces, especially those of the respiratory (8, 12) and digestive (11, 19) tracts. In immunocompetent humans, Cryptosporidium infection may produce a self-limited flulike gastrointestinal illness (1-3, 7) that resolves spontaneously in 1 to 4 weeks (7, 15, 16) . In immunocompromised patients, particularly those with acquired immunodeficiency syndrome, Cryptosporidium sp. may produce severe and prolonged diarrhea which does not respond to treatment and which contributes to mortality. Evaluation of anti-Cryptosporidium drugs based on the therapeutic outcomes of patients with acquired immunodeficiency syndrome has methodological limitations and was not successful in identifying efficient therapy (4) . The use of endodermal cells from the chorioallantoic membranes of chicken embryos (6), human fetal lung cells, primary chicken kidney cells, or pig kidney cells in culture (5) has been proposed for the in vitro evaluation of antiprotozoan drugs. These methods provide oocysts for only a short period and are not easily performed.
Therefore, the development of a reliable animal model is crucial for the evaluation of various drugs for prophylaxis or therapy. In vivo, controlled animal studies were conducted with antibiotics, sulfamides, and antiparasitic agents in calves (14) and mice (21) and with ornithine decarboxylase inhibitors in pigs (13) . However, immunocompetent animals often either do not become infected, exhibit a self-limiting infection (17) , or die soon after becoming infected. In one successful model, nude mice challenged at 6 days of age with oocysts had persistent Cryptosporidium infections until day 56, the end of experiment (9) .
The aim of our study was to establish a persistent Cryptosporidium infection in a small animal. The validity of a rodent model as a model of human cryptosporidiosis is supported (i) by the identification of the parasite in the different hosts (20) and (ii) by the similarity of infections in both immunosuppressed humans and rodents (10 Rat feces were collected daily and stored suspended in a 10% (wt/vol) Formalin solution at 4°C. Oocysts were detected by phase-contrast microscopy in smears from 10 ,ul of homogenized fecal suspension specimen mixed with 10 ,ul of a carbolfuchsin solution (9) . Cryptosporidium shedding was measured by counting oocysts per microscopic field (MF) under x400 magnification. A total of 10 to 100 MF were observed, depending on the density of parasites in each specimen. Shedding was evaluated for each rat as the mean numbers of oocysts per MF and per day.
With five infected rats, gastrointestinal tract, jejunal, and ileal tissue sections, performed 2 weeks after challenge, were examined after normal Formalin fixation, paraffin embedding, and hematoxylin-eosin staining. In the jejunum and ileal sections of the infected rats, diffuse atrophy of villi and hyperplasia of crypts were observed, associated with the presence of oocysts fixed to epithelial cells. These features were absent in three noninfected control rats.
Statistical comparisons between groups were performed by using the Fisher and Yates chi-square tests, and variance analysis was done with the Mann-Whitney U test.
In group 1, all animals began to shed oocysts on days 2 to 9 after challenge. The shedding peaked on days 7 to 23. Of 32 rats, 25 survived; the others died between days 17 and 24.
No significant difference in the counts of oocysts shed was noted between the survivors and dead animals. Of 25 surviving rats, 22 ceased to shed oocysts 10 to 13 days following restoration of a normal diet (38 to 41 days after challenge).
Of the three others with a continued low-protein diet, two died and one was still shedding oocysts after day 100. As shown in Table 1 , excretion of oocysts occurred earlier in group 1 than in groups 2 and 3. The peak and mean values of shedding were significantly higher in group 1 than in group 2 (P = 0.05 and P < 0.01, respectively). For group 3, the difference with group 2 was not significant for the peak value of excretion or for the mean value of shedding (P = 0.3 and P = 0.2, respectively). With the control group which did not receive hydrocortisone acetate and which had a normal diet, no oocysts were found in the feces during the time of the experiment (days 0 to 30), and the unchallenged immunosuppressed control rats did not excrete oocysts in any fecal specimen.
Although several drugs, including spiramycin, pentamidine, and tetracycline, have been clinically tested (15) , effective treatment for Cryptosporidium infection has yet to be found for immunocompromised hosts. Development of effective treatment has been limited by the lack of a simple method for screening the efficacies of drugs.
The lack of host specificity has been confirmed, and evidence has been provided that a single Cryptosporidium species is found in mammals, including humans (20) ; Cryptosporidium oocysts of human and calf origins produced indistinguishable infection in suckling mice, rats, and adult mice when they were challenged orally (16) . In our experiments with oocysts from naturally infected calves, oocysts were detected from days 2 to 9 following inoculation, a time interval similar to that found with other animal models, such as lambs (19) , nude mice (10), or calves (11) . Peak oocyst counts per MF were found to be higher than in nude mice (10) . The mortality rate reached 21%, and in surviving animals infection persisted as long as they received hydrocortisone acetate and a low-protein diet. In recent experiments, a low-protein diet alone was found to be more effective in maintaining Cryptosporidium infection than hydrocortisone acetate alone, as previously observed in an experimental rat model for P. carinii infection (22) . This suggests that susceptibility to Cryptosporidium infection could be enhanced by protein malnutrition.
Optimum oocyst excretion was observed in primarily infected animals, and excretion decreased after subsequent infection challenges under the same diet and immunosuppressive conditions. This suggests that a degree of protection developed progressively, and it should be further determined whether T cells are required for recovery, as previously demonstrated with mice (10) .
This experimental immunosuppressed-rat model is suitable for screening candidate therapeutic agents and can be used to study either preventive or curative activities of drugs.
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